Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adipose-derived stromal cells (ADSCs) are mesenchymal stem cells derived from adipose tissue. They play a significant role in regenerative medicine by promoting tissue regeneration through differentiation into various cell types and paracrine secretion of growth factors and cytokines. ADSCs are used in treatments for wounds, nerve damage, cardiovascular diseases, and other conditions due to their ability to enhance tissue repair and modulate immune responses. Despite their potential, there are concerns regarding safety, including oncological risks and the need for optimized cell preparation methods.
Paracrine and immunomodulatory effects; Differentiation into various cell types; Secretion of angiogenic factors (e.g., VEGF, PDGF-BB) for tissue neovascularization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adipose-derived stromal cell-mediated tissue regeneration (ADSC-mediated tissue regeneration or ADSCs).